Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

niche pharma ltd - chloramphenicol - ear drops - 100mg/1ml

Stati Uniti - Ingliż - NLM (National Library of Medicine)

bimeda, inc. - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) - chloramphenicol 250 mg - indications : chloramphenicol tablets are recommended for oral treatment of the following conditions in dogs: - bacterial pulmonary infections caused by susceptible microorganisms such as: staphylococcus aureus , streptococcus pyogenes and brucella bronchiseptica . - infections of the urinary tract caused by susceptible microorganisms such as: escherichia coli , proteus vulgaris , corynebacterium renale , streptococcus spp., and hemolytic staphylococcus . - enteritis caused by susceptible microorganisms such as: e. coli , proteus spp., salmonella spp., and pseudomonas spp. - infections associated with canine distemper caused by susceptible microorganisms such as: b. bronchiseptica , e. coli , p. aeruginosa , proteus spp., shigella spp. and neisseria catarrhalis . additional adjunctive therapy should be used when indicated. most susceptible infectious disease organisms will respond to chloramphenicol therapy in three to five days when the recommended dosage regimen is followed. if no response to chloram

Stati Uniti - Ingliż - NLM (National Library of Medicine)

parke-davis - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) - ointment - chloramphenicol should be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. bacteriological studies should be performed to determine the causative organisms and their sensitivity to chloramphenicol (see boxed warning). chloromycetin ophthalmic ointment, 1% (chloramphenicol ophthalmic ointment, usp) is indicated for the treatment of surface ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol-susceptible organisms. the particular antiinfective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus streptococcus , including streptococcus pneumoniae escherichia coli haemophilus influenzae klebsiella/enterobacter species moraxella lucunata     (morax-axenfeld bacillus) neisseria species this product does not provide adequate coverage against: pseudomonas aeruginosa serratia marcescens this product is contraindicated in persons sensitive to any of its components.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

ethypharm - chloramphenicol - eye ointment - 1 percent weight/weight - antibiotics; chloramphenicol

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - chloramphenicol, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: borax; water for injections; phenylmercuric nitrate; hypromellose; boric acid - for the treatment of bacterial conjunctivitis. for use under medical supervision only in the treatment of other superficial ocular infections caused by chloramphenicol-sensitive organisms.

Kenja - Ingliż - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road near leela hotel - chloramphenicol sodium succinate injection bp 1g - powder for injection - each vial contains: chloramphenicol sodium… - antibacterials for systemic use: amphenicols

Kanada - Ingliż - Health Canada

pharmascience inc - chloramphenicol - drops - .5% - chloramphenicol .5% - antibacterials

Kanada - Ingliż - Health Canada

pharmascience inc - chloramphenicol - ointment - 10mg - chloramphenicol 10mg - antibacterials

Namibja - Ingliż - Namibia Medicines Regulatory Council

sandoz (sa) (pty) ltd - chloramphenicol - capsule - chloramphenicol 250mg

Iżrael - Ingliż - Ministry of Health

teva israel ltd - chloramphenicol - ointment - chloramphenicol 3 % - chloramphenicol - chloramphenicol - antibiotic.